Sample Taker Training Cervical Cytology & Management of Abnormalities.

Slides:



Advertisements
Similar presentations
Cervical Screening Guidelines - for now and the future - Meg McLachlin, MD, FRCPC.
Advertisements

Cervical Issues Annual update 2010 Tamsin Groom. Overview of screening and management Do’s and Don’ts The “suspicious cervix” Quiz.
The Cytology Laboratory Chris Faraker Clinical Cytologist East Sussex Healthcare Trust.
MANAGEMENT OF ABNORMAL PAP SMEAR
Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Sample Takers 2014 Cervical Sample Taker Training
Gynaecological Cancers
Sample Taker Training Anatomy & Physiology of Pelvic Organs.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Benign Conditions Of The Cervix Dr. Abdalla H. Elsadig MD.
Screening for Cervical Cancer
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA Roger J Rand.
Benign and premalignant disease of the cervix
Cervical Cancer: Prevention and Treatment
Post Menopausal Bleeding
Hormonal cytology of female genital tract
COLPOSCOPY Cervical Screening QARC Training School October 2012.
Cervical Cancer Screening
The Role of the Cytology Laboratory
Key Information about CervicalCheck for Non-Medical Staff in Primary Care.
Screening Tests for Brest & Cervical Cancer
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Key Information About CervicalCheck for Non-medical Staff in Primary Care.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
Overview of NHS Cervical Screening Programme Cervical Screening QARC Training School October 2012.
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Tumors of Cervix.
NHS Cervical Screening Programme, England, : Graphs.
Hot Topics Clinical Medicine ACHA Annual Meeting Boston, MA May 31, 2013.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Screening.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Adult Medical-Surgical Nursing
Cases. Case 2 Case 3 Normal cervix - Spatula and brush.
‘Let’s get it right - Referral for suspected Cancer’
CERVICAL SCREENING UPDATE Louise Cadman Research Nurse Consultant and Nurse Colposcopist Centre for Cancer Prevention Wolfson Institute of Preventive Medicine.
Cytologic Findings in Type 2 Cervical Carcinomas: Some Cervical Carcinomas are more Difficult to Prevent with Screening R. Marshall Austin MD,PhD Magee-Womens.
1 Cervical Screening Programme, England, : Graphs.
Premalignant lesions of the cervix. Applied anatomy.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
CERVICAL SCREENING ANGELIKA KAUFMANN, ST4, UHCW, MEDICAL STUDENT INDUCTION, 2015.
NHS Cervical Screening Programme Introducing HPV triage and test of cure.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
Cytopathology Feb
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Chris Marshall Cardiff 4 th year Medical Student.
Understanding Test Results
Public Health England leads the NHS Screening Programmes
NHS Cervical Screening Programme Introducing HPV Triage
Endometrial hyperplasia
Post Menopausal Bleeding
Cytology Codes & management Colposcopy- Management of cervical lesions
Cervical Cancer Colposcopy & Treatment
Cervical Screening Programme, England, : Graphs
NHS Cervical Screening Programme, England, : Graphs
Dr N Shailaja Dr Pradeep
Cervical cancer & screening
Pap smear interpretation
Updates on Pap Smear Guidelines 2014
Public Health England leads the NHS Screening Programmes
SH-sheikhhasani Gyn-oncologist
Cervical Screening Programme
Presentation transcript:

Sample Taker Training Cervical Cytology & Management of Abnormalities

Cervical Cytology Results Negative Negative with infection Unsatisfactory Abnormal

Types of Cells Seen

Mature Cell Pattern Pre-menopause HRT Oestrogen cream Tamoxifen Obese women

Immature Cell Pattern – Oestrogen Deficient Post menopausal Post-natal Depoprovera

Evidence of Transformation Zone Sampling Endocervical Cells and/or Metaplastic Cells

Background Blood Cells Polymorphs Red Blood Cells A lot of the blood is removed during processing but occasionally may be noticeable in the background of the sample

Endometrial Cells These come from the womb lining May be shed during menstruation together with blood

Late Menstrual Cycle Cells break up & some detail is lost

Best time to take a smear? Menstruation – no (Days 1-5) Proliferative phase – OK Ovulation – OK Avoid the later days of the cycle if possible

Infections Candida Trichomonas (TV) Herpes Rarely worm eggs may be seen = contaminant

Unsatisfactory Samples Reason for unsatisfactory given in report –May help when taking repeat sample e.g. treatment of infection or topical oestrogen treatment Repeat in 3 months (minimum) After 3 unsatisfactory samples – refer to colposcopy

Abnormal Results

Cervical Abnormalities May be squamous or glandular in origin Non-cervical abnormalities including metastatic cancer may be seen (rare)

Abnormalities That May Be Seen On Cervical Samples Squamous Abnormalities - CIN (Cervical Intraepithelial Neoplasia) Endocervical Abnormalities (Glandular Neoplasia) Glandular Neoplasia (non-cervical) – cells may shed but NOT directly sampled

Squamous Dyskaryosis Cytological term meaning abnormal nucleus

Progression of CIN Normal Cells Low grade dyskaryosis Borderline changes Moderate dyskaryosis Severe dyskaryosis Cancer Treatment Normal If left untreated (36%) HPV / Smoking etc.

Squamous Abnormalities Borderline Changes Mild dyskaryosis Moderate dyskaryosis Severe Dyskaryosis Severe/?invasive carcinoma Low Grade High Grade

Borderline Changes Minor changes seen but not dyskaryotic

CIN 1CIN 2CIN 3 mildmoderateseverenormal

CIN1 CIN2 CIN3 (in a crypt) CANCER MILD DYSK MODERATE SEVERE SEV/?INV Basement membrane

Cervical Cancer - Squamous

Management Low grade High grade Severe dyskaryosis / ?invasion HPV test to decide management Colposcopy referral URGENT colposcopy referral

Glandular Abnormalities That May Be Seen On Cervical Samples Endocervical Abnormalities (Glandular Neoplasia) Glandular Neoplasia (non-cervical) – cells may shed but NOT directly sampled

Glandular Abnormalities Borderline Changes ?Glandular Neoplasia (Cervix) ?Glandular Neoplasia (Other) HPV Test to decide management Urgent referral to colposcopy Urgent referral to gynae

Do not delay referrals if clinical symptoms A negative cervical sample does NOT exclude a non-cervical abnormality e.g. womb cancer, ovarian cancer Post menopausal bleeding – refer to gynae If cervix looks suspicious refer to colposcopy Don’t wait for cytology result

Malignant looking cervix

Summary of Management Low grade abnormalities HPV test High grade dyskaryosis Colposcopy Glandular abnormalities Cervical Non-cervical +ve -ve Routine Recall Gynae

Early Repeat Tests If HPV testing is not performed early repeat tests may be requested. –Repeat interval indicated on report –Patient recalled by letter

Early Repeat Samples - HPV Test NOT Performed Low grade abnormalities –6 or 12 month repeat samples (3 negative results before return to routine recall) High grade abnormalities after treatment –12 month repeat samples (10 annual repeats before return to routine recall)

Management after Hysterectomy NOT followed up by the CERVICAL screening programme – cease recall –Follow up is the responsibility of the Gynaecologist